£520.00

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in the United States

Price data last checked 78 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 13 days • 13 data points (No recent data available)

Historical
Generating forecast...
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 26 January 2026 29 January 2026 01 February 2026 04 February 2026 07 February 2026

Price Distribution

Price distribution over 13 days • 1 price levels

Days at Price
13 days 0 3 7 10 13 £520 Days at Price

Price Analysis

Most common price: £520 (13 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 13 days

Product Specifications

Format
Paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in India
98% match

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in India

£515.00 06 Feb 2026
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States
97% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States

£520.00 28 Jan 2026
The 2023-2028 Outlook for Myopia and Presbyopia Treatments in the United States
97% match

The 2023-2028 Outlook for Myopia and Presbyopia Treatments in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Macular Degeneration Treatments in the United States
97% match

The 2023-2028 Outlook for Macular Degeneration Treatments in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Gonorrhea Therapeutics in the United States
97% match

The 2023-2028 Outlook for Gonorrhea Therapeutics in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States
97% match

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Vision Care in the United States
97% match

The 2023-2028 Outlook for Vision Care in the United States

£520.00 11 Jan 2026
The 2023-2028 Outlook for Pseudotumor Cerebri in the United States
97% match

The 2023-2028 Outlook for Pseudotumor Cerebri in the United States

£520.00 07 Feb 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
97% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in the United States
97% match

The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Insomnia Therapeutics in the United States
97% match

The 2023-2028 Outlook for Insomnia Therapeutics in the United States

£520.00 15 Jan 2026
The 2023-2028 Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs in the United States
97% match

The 2023-2028 Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs in the United States

£520.00 01 Feb 2026
The 2023-2028 Outlook for Dry Eye Syndrome Treatments in the United States
97% match

The 2023-2028 Outlook for Dry Eye Syndrome Treatments in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States
96% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States

£520.00 03 Feb 2026
The 2023-2028 Outlook for Optical Goods and Eye Care Products in the United States
96% match

The 2023-2028 Outlook for Optical Goods and Eye Care Products in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Glass Lens Vision Care in the United States
96% match

The 2023-2028 Outlook for Glass Lens Vision Care in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in the United States
96% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Eye Allergy Treatments in the United States
96% match

The 2023-2028 Outlook for Eye Allergy Treatments in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Statins in the United States
96% match

The 2023-2028 Outlook for Statins in the United States

£520.00 26 Jan 2026
The 2023-2028 Outlook for Amyloidosis Treatments in the United States
96% match

The 2023-2028 Outlook for Amyloidosis Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in the United States
96% match

The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Syringes in the United States
96% match

The 2023-2028 Outlook for Syringes in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Phycocyanin in the United States
96% match

The 2023-2028 Outlook for Phycocyanin in the United States

£520.00 19 Feb 2026
The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in the United States
96% match

The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in the United States

£520.00 07 Feb 2026